Benefits of supplementing St Thomas’ Hospital cardioplegic solution with tetraethylammonium on functional and metabolic recovery of isolated rat hearts

Vascular

Volumn 5, Issue 1, 1997, Pages 117-124

  Bozkurt, A K ^a   Suzer o ^a   Kaynar, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

myocardial protection; potassium channel blockers; potassium channels; tetraethylammonium

Indexed keywords

4 AMINOPYRIDINE; CARDIOPLEGIC AGENT; GLIBENCLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; ST THOMAS HOSPITAL SOLUTION; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART MUSCLE METABOLISM; HEART PROTECTION; MALE; NONHUMAN; OPEN HEART SURGERY; PRIORITY JOURNAL; RAT;

4-AMINOPYRIDINE; ANIMALS; BICARBONATES; CALCIUM CHLORIDE; CARDIOPLEGIC SOLUTIONS; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; FEMALE; GLYBURIDE; HEART ARREST, INDUCED; MAGNESIUM; MALE; MYOCARDIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; SODIUM CHLORIDE; TETRAETHYLAMMONIUM; TETRAETHYLAMMONIUM COMPOUNDS;

EID: 0030979433     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721099700500120     Document Type: Article

References (28)

1. Kirklin J. W., Barrat-Boyes B. G., Cardiac Surgery. 2nd ed, Churchill Livingstone, New York, 1993, pp. 129–166.
2. Tayayashi K., Suziki Y., Nagamine S., Ito Y., Sekino Y., Mohri H., A clinical trial of allopurinol (Zycloric) for myocardial protection. Journal of Thoracic and Cardiovascular Surgery, 1991, 101(4), 713–718.
3. Zweng T. N., Lynch M. J., Bove E. L., Recovery of the neonatal heart after normothermic ischemia. Effect of oxygen catalase. Journal of Thoracic and Cardiovascular Surgery, 1991, 101(1), 326–336.
4. Melendez F. J., Gharagozloo F., Sun S. C., Effects of diltiazem cardioplegia on global function, segmental contractility and the area of necrosis after acute coronary artery occlusion and surgical reperfusion. Journal of Thoracic and Cardiovascular Surgery, 1988, 95(4), 613–617.
5. Landymore R. W., Marble A. E., McAulay M. A., Li Q. Y., Fris J., Oxygenated cardioplegia ameliorates the adverse effects of small amplitude electrical recording of activity on myocardial metabolic and functional recovery. European Journal of Cardiothoracic Surgery, 1991, 5(1), 37–40.
6. Julia P. I., Buckberg G. D., Acar C., Partington M. T., Sherman M. P., Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: Superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage — Importance of endogenous oxygen free radical scavengers in red blood cells. Journal of Thoracic and Cardiovascular Surgery, 1991, 101(2), 303–313.
7. Eskande D., Henry P., Potassium channels as pharmacological targets in cardiovascular medicine. European Heart Journal, 1993, 14(Suppl B), 2–9.
8. Haeusler G., Lues I., Therapeutic potential of potassium channel activators in coronary heart disease. European Heart Journal, 1994, 15(Suppl C), 82–88.
9. Langton P. D., Nelson M. T., Huang Y., Standen N. B., Block of calcium-activated potassium channels in mammalian arterial myocytes with tetraethylammonium ions. American Journal of Physiology, 1991, 260(3 part 2), H927-H934.
10. Benham C. D., Bolton T. B., Lang R. J., Takewaki K., The mechanism of action of Ba and tetraethylammonium on single Ca activated K channels in arterial and intestinal smooth muscle cell membranes. Pflügers Archiv, 1985, 403(2), 120–127.
11. Süzer Ö., Decreasing the injury of calcium paradox by potassium depolarization and tetraethylammonium in isolated rat hearts. PhD thesis, University of Istanbul, Cerrahpaşa Faculty of Medicine, Department of Pharmacology, 1993.
12. Tosaki A., Hellegouarch A., Adenosine triphospate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravate, ischema/reperfusion injury. Heart function studies in nonfibrillating isolated hearts. Journal of the American College of Cardiology, 1994, 23, 487–496.
13. Rankin J. S., Sabiston D. C., Physiology of coronary blood flow, myocardial function, and intraoperative myocardial protection. In Surgery of the Chest, Vol. 2, 5th edn, ed. Sabiston D. C., W.B Saunders Company, Philadelphia, 1990, pp. 1635–1655.
14. Bigger J. T., The electrical activity of the heart. In The Heart, ed. Hurst J. W., McGraw-Hill, New York, 1990, pp. 77–90.
15. Reimer K. A., Jennings R. B., Myocardial ischemia, hypoxia and infarction. In The Heart and Cardiovascular System, ed. Fozzard H. A., Haber E., Jennings R. B., Katz A. M., Morgan H. E., Raven, New York, 1992, pp. 1875–1973.
16. Carmeliet E., K channels in cardiac cells: Mechanism of activation, inactivation, rectification and K+ sensitivity. Pflügers Archiv, 1989, 414(Suppl 1), S88-S92.
17. Roberds S. L., Knoth K. M., Po S., Molecular biology of the voltage-gated potassium channels of the cardiovascular system. Journal of Cardiovascular Electrophysiology, 1993, 4(1), 68–80.
18. Cohen N. K., Wise R. M., Wechsier A. S., Damiano R. J., Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. Journal of Thoracic and Cardiovascular Surgery, 1993, 106, 317–328.
19. Sugimoto S., Puddu P. E., Monti F., Schiariti M., Campa P. P., Marino B., Pretreatment with adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia. Journal of Thoracic and Cardiovascular Surgery, 1994, 108, 455–466.
20. Marijic J., Buljubasic N., Coughlan G., Karnopine J. P., Bosnjak Z. J., Effect of K channel blockade with tetraethylammonium on anesthetic-induced relaxation in canine cerebral and coronary arteries. Anesthesiology, 1992, 77, 948–955.
21. Cole W. C., ATP-sensitive K+ channels in cardiac ischemia: an endogenous mechanism for protection of the heart. Cardiovascular Drugs and Therapy, 1993, 7(Suppl 3), 527–537.
22. Narishige T., Egashira K., Akatsuka Y., Glibenclamide, a putative ATP-sensitive K channel blocker inhibits coronary autoregulation in anesthetized dogs. Circulation Research, 1993, 73(4), 771–776.
23. McPherson C. D., Pierce G. N., Cole W. C., Ischemic cardioprotection by ATP-sensitive K channels involves high-energy phosphate preservation. American Physiologist, 1993, 265(5 Part 2), H1809-H1818.
24. Grover G. J., McCullough J. R., Henry D. E., Conder M. L., Sleph P. G., Anti-ischemic effects of potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide. Journal of Pharmacology and Experimental Therapeutics, 1989, 251(1), 98–104.
25. Khan A. R., Edman K. A., Effects of 4-aminopyridine on the excitation-contraction coupling in frog and rat skeletal muscle. Acta Physiologica Scandinavica, 1979, 105(4), 443–452.
26. Kirklin J. W., Barrat-Boyes B. G., Myocardial protection during cardiac surgery with cardiopulmonary by-pass. In Cardiac Surgery, 1st edn. Wiley Medical Publication, New York, 1986, pp. 83–108.
27. Thuringer D., Sauve R., A patch-clamp study of the Ca mobilization from internal stores in bovine aortic endothelial cells. I. Effects of caffeine on intracellular Ca stores. Journal of Membrane Biology, 1992, 130(2), 125–137.
28. Thuringer D., Sauve R., A patch-clamp study of the Ca mobilization from internal stores in bovine aortic endothelial cells. II. Effects of thapsigargin on the cellular Ca homeostasis. Journal of Membrane Biology, 1992, 130(2), 139–148.